Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32
Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flucloxacillin BP 500mg Capsules.
DMRC reference number
DMRC-39902702
Marketing Authorisation Holder
Flamingo Pharma UK Ltd
Medicine Details
Flucloxacillin Capsules BP 500mg
PL: 43461/0071
Active ingredient: flucloxacillin sodium
SNOMED code: 42544111000001101
GTIN: 5060464503320
Affected Lot Batch Numbers
| Batch No. | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 1600636 | 31/08/2028 | 28 Capsules | 19/05/2026 |
Background
Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flucloxacillin BP 500mg Capsules. Flamingo Pharma UK Ltd estimate that the number of impacted is low however as a precautionary measure, this batch is being recalled.
Advice for Healthcare Professionals:
Stop supplying the affected batch. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Advice for Patients:
Patients should be aware that the Patient Information Leaflet (PIL) in a small number of packs of Flucloxacillin BP 500mg Capsules is incorrect. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flucloxacillin 500mg Capsules.
Patients may continue to take the capsules as prescribed by your doctor as the quality of the capsules is not impacted by this defect.
No further action is required by patients. This recall is being undertaken as a precautionary measure and applies at Pharmacy and Wholesaler level.
The correct PIL may be found at: Click Here.
Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Additional information:
For all medical information enquiries and information on this product, please email safety@flamingopharma.co.uk, or telephone +44 (0) 800 0668 348.
For stock control enquiries please email sales@flamingopharma.co.uk, or telephone +44 (0) 7784 240228
Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Yours faithfully
Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574
Download document